AIM ImmunoTech Market Cap

AIM ImmunoTech has a market cap or net worth of $3.83 million as of January 9, 2026. Its market cap has decreased by -68.37% in one year.

Market Cap

3.83M

Enterprise Value

3.75M

1-Year Change

-68.37%

Ranking

n/a

Market Cap Chart

Since December 1, 1998, AIM ImmunoTech's market cap has decreased from $159.10M to $3.83M, a decrease of -97.59%. That is a compound annual growth rate of -12.84%.

Market Cap History

Date	Market Cap	% Change
Jan 8, 2026	3.80M	18.75%
Dec 31, 2025	3.20M	-74.60%
Dec 31, 2024	12.60M	-41.40%
Dec 29, 2023	21.50M	43.33%
Dec 30, 2022	15.00M	-65.91%
Dec 31, 2021	44.00M	-39.56%
Dec 31, 2020	72.80M	1,517.78%
Dec 31, 2019	4.50M	-48.28%
Dec 31, 2018	8.70M	-20.91%
Dec 29, 2017	11.00M	-33.73%
Dec 30, 2016	16.60M	-16.58%
Dec 31, 2015	19.90M	-60.20%
Dec 31, 2014	50.00M	12.61%
Dec 31, 2013	44.40M	17.15%
Dec 31, 2012	37.90M	43.02%
Dec 30, 2011	26.50M	-60.27%
Dec 31, 2010	66.70M	-10.23%
Dec 31, 2009	74.30M	166.31%
Dec 31, 2008	27.90M	-50.09%
Dec 31, 2007	55.90M	-60.04%
Dec 29, 2006	139.90M	19.27%
Dec 30, 2005	117.30M	24.79%
Dec 31, 2004	94.00M	10.33%
Dec 31, 2003	85.20M	24.56%
Dec 31, 2002	68.40M	-50.18%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	992.16B
Johnson & Johnson	499.90B
AbbVie	412.54B
UnitedHealth Group	309.53B
AstraZeneca	297.23B
Novartis AG	273.49B
Merck & Co.	269.55B
Novo Nordisk	254.60B

Market Cap Rankings